Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Expert Consensus Statements

ESMO-Expert-Consensus-Statements-1000x250

The ESMO Expert Consensus Statement series of publications contain recommendations on well-defined, controversial or clinically relevant topics and are produced by 20-40 key experts in the field.

The publications tackle focused oncological aspects within a specific tumour type or across tumours. By addressing a more narrow topic than a traditional ESMO Clinical Practice Guideline, they offer an in-depth study of the field and provide recommendations that complement the latter, often in scientific or practice areas in which high-level evidence is lacking. Production of the ECS publications is based on a narrative literature review followed by iterative rounds of Statement production, Delphi-based voting and Statement revision that involve all experts until consensus is reached.

Available ECS Publications

ESMO Expert Consensus Statements on the Screening and Management of Financial Toxicity in Patients with Cancer ESMO Expert Consensus Statements on the Screening and Management of Financial Toxicity in Patients with Cancer

Published 15 April 2024 - ESMO Open
Authors: P.M. Carrera, G. Curigliano, D. Santini, L. Sharp, R.J. Chan, M. Pisu, F. Perrone, S. Karjalainen, G. Numico, N. Cherny, E. Winkler, M.L. Amador, M. Fitch, M. Lawler, F. Meunier, N. Khera, G. Pentheroudakis, D. Trapani, C.I. Ripamonti

ESMO Expert Consensus Statements on the Management of Breast Cancer During Pregnancy (PrBC) ESMO Expert Consensus Statements on the Management of Breast Cancer During Pregnancy (PrBC)

Published 10 August 2023 - Ann Oncol
Authors: S. Loibl, H.A. Azim Jr., T Bachelot, P. Berveiller, A. Bosch, E. Cardonick, C. Denkert, M.J. Halaska, M. Hoeltzenbein, A.L.V. Johansson, C. Maggen, U.R. Markert, F. Peccatori, P. Poortmans, E. Saloustros, C. Saura, P. Schmid, E. Stamatakis, M. van den Heuvel-Eibrink, M. van Gerwen, V. Vandecaveye, G. Pentheroudakis, G. Curigliano, F. Amant

ESMO Expert Consensus Statements on the Definition, Diagnosis, and Management of HER2-low Breast Cancer ESMO Expert Consensus Statements on the Definition, Diagnosis, and Management of HER2-low Breast Cancer

Published 01 June 2023 - Ann Oncol
Authors: Paolo Tarantino, Giuseppe Viale, Michael F. Press, Xichun Hu, Frederique Penault Llorca, Aditya Bardia, Anna Batistatou, Harold J. Burstein, Lisa A. Carey, Javier Cortes, Carsten Denkert, Véronique Diéras, William Jacot, Angelos K. Koutras, Annette Lebeau, Sibylle Loibl, Shanu Modi, Maria Fernanda Mosele, Elena Provenzano, Giancarlo Pruneri, Jorge S. Reis Filho, Federico Rojo, Roberto Salgado, Peter Schmid, Stuart J. Schnitt, Sara M. Tolaney, Dario Trapani, Anne Vincent-Salomon, Antonio C Wolff, George Pentheroudakis, Fabrice André, Giuseppe Curigliano

ESMO Expert Consensus Statements on Cancer Survivorship: Promoting High-Quality Survivorship Care and Research in Europe ESMO Expert Consensus Statements on Cancer Survivorship: Promoting High-Quality Survivorship Care and Research in Europe

Published 10 August 2022 – Ann Oncol
Authors: Ines Vaz-Luis, Marianna Masiero, Guido Cavaletti, Andres Cervantes, Rowan T. Chlebowski, Giuseppe Curigliano, Enriqueta Felip, Arlindo R. Ferreira, Patricia A. Ganz, Josephine Hegarty, Justin Jeon, Christoffer Johansen, Florence Joly, Karin Jordan, Bogda Koczwara, Pernilla Lagergren, Matteo Lambertini, Daniel Lenihan, Helena Linardou, Charles Loprinzi, Ann H. Partridge, Stefan Rauh, Karen Steindorf, Winette van der Graaf, Lonneke van de Poll-Franse, George Pentheroudakis, Solange Peters, Gabriella Pravettoni

ESMO Expert Consensus Statements on the Management of EGFR Mutant Non-Small-Cell Lung Cancer ESMO Expert Consensus Statements on the Management of EGFR Mutant Non-Small-Cell Lung Cancer

Published 14 February 2022 – Ann Oncol
Authors: A. Passaro, N. Leighl, F. Blackhall, S. Popat, K. Kerr, M.J. Ahn, M.E. Arcila, O. Arrieta, D. Planchard, F. de Marinis, A.M. Dingemans, R. Dziadziuszko, C. Faivre-Finn, J. Feldman, E. Felip, G. Curigliano, R. Herbst, P.A. Jänne, T. John, T. Mitsudomi, T. Mok, N. Normanno, L. Paz-Ares, S. Ramalingam, L. Sequist, J. Vansteenkiste, I.I. Wistuba, J. Wolf, Y.L. Wu, S.R. Yang, J.C.H. Yang, Y. Yatabe, G. Pentheroudakis, S. Peters

Managing Hematological Cancer Patients During the Covid-19 Pandemic: An ESMO-EHA Interdisciplinary Expert Consensus Managing Hematological Cancer Patients During the Covid-19 Pandemic: An ESMO-EHA Interdisciplinary Expert Consensus

Published 27 January 2022 – ESMO OPEN
Authors: C. Buske, M. Dreyling, A. Alvarez-Larrán, J. Apperley, L. Arcaini, C. Besson, L. Bullinger, P. Corradini, M. Giovanni Della Porta, M. Dimopoulos, S.D’Sa, H. T. Eich, R. Foà, P. Ghia, M. G. da Silva, J. Gribben, R. Hajek, C. Harrison, M. Heuser, B. Kiesewetter, J. J. Kiladjian, N. Kröger, P. Moreau, J. R. Passweg, F. Peyvandi, D.Rea, J.-M. Ribera, T. Robak, J. F. San-Miguel, V. Santini, G. Sanz, P. Sonneveld, M. von Lilienfeld-Toal, C. Wendtner, G. Pentheroudakis & F. Passamonti

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.